Tirzepatide 10mg
Tirzepatide is a synthetic 39-amino-acid peptide that activates both the GLP-1 and GIP receptors. It is the first of a new class of dual incretin agonists and carries an extensive clinical-trial record. Supplied for laboratory research use only. Not for human or veterinary use.
A dual GLP-1 and GIP receptor agonist.
Tirzepatide is a synthetic 39-amino-acid peptide that activates both the GLP-1 and GIP receptors. It is the first of a new class of dual incretin agonists and carries an extensive clinical-trial record.
What the research shows
Studies have documented effects on glucose homeostasis, insulin secretion and body-weight regulation. The dual mechanism produces stronger metabolic effects than GLP-1-only agonists.
The SURPASS and SURMOUNT phase 3 programmes provide comprehensive efficacy and safety data, along with dose-response and pharmacokinetic profiles.
Why researchers choose Aevryn Labs
Every batch is tested at a leading Australian university, where HPLC and mass spectrometry confirm a purity of 99% or higher. No generic overseas certificates.
Read the full research guide
